The path forward for idiopathic hypersomnia starts with new research.
Consider the ONSTRIDE-2 study.
About the ONSTRIDE-2 study
This clinical study is assessing an investigational drug for idiopathic hypersomnia in people 18 years of age or older and is seeking volunteers.
A person may qualify to participate in the ONSTRIDE-2 study if they are:
18 years of age or older
Diagnosed with idiopathic hypersomnia
If on a stable dose of a current medication, must continue it through study completion
Not pregnant or planning pregnancy
Not on a prohibited medication
Able to give informed consent
This is not a complete list of study requirements. The study doctor will review all of the requirements with you.
It is important to study the investigational drug in a wide range of people with idiopathic hypersomnia. We are looking for ALL types of people living with idiopathic hypersomnia to enroll—including adults who are of any race, ethnic origin, or gender.
Download the study brochure
The study brochure provides information similar to the information on this website to help you discuss participation in the ONSTRIDE-2 study with your doctor. You can also share the brochure with someone who may be interested in this study.
Learn more